Drug recall · July 15, 2015
Bupivacaine Hydrochloride Inj recall
Why: Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.
- Lots / codes
Lot #: 38-515-DK, Expiry: 1 FEB 2016.
- Quantity
- 150,950 Vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- U.S. Nationwide including Guam.
- Initiated
- April 23, 2015 · Voluntary: Firm initiated
- Classified
- July 8, 2015
- Reported
- July 15, 2015
- Ended
- January 26, 2016
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.